Correlation Between Spire Global and Nanobac Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Spire Global and Nanobac Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spire Global and Nanobac Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spire Global and Nanobac Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Spire Global and Nanobac Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spire Global with a short position of Nanobac Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spire Global and Nanobac Pharmaceuticals.
Diversification Opportunities for Spire Global and Nanobac Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Spire and Nanobac is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spire Global and Nanobac Pharmaceuticals Incorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanobac Pharmaceuticals and Spire Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spire Global are associated (or correlated) with Nanobac Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanobac Pharmaceuticals has no effect on the direction of Spire Global i.e., Spire Global and Nanobac Pharmaceuticals go up and down completely randomly.
Pair Corralation between Spire Global and Nanobac Pharmaceuticals
If you would invest 1,000.00 in Spire Global on September 3, 2024 and sell it today you would earn a total of 634.00 from holding Spire Global or generate 63.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spire Global vs. Nanobac Pharmaceuticals Incorp
Performance |
| Timeline |
| Spire Global |
| Nanobac Pharmaceuticals |
Spire Global and Nanobac Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spire Global and Nanobac Pharmaceuticals
The main advantage of trading using opposite Spire Global and Nanobac Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spire Global position performs unexpectedly, Nanobac Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanobac Pharmaceuticals will offset losses from the drop in Nanobac Pharmaceuticals' long position.| Spire Global vs. Lichen China Limited | Spire Global vs. Unifirst | Spire Global vs. First Advantage Corp | Spire Global vs. Performant Financial |
| Nanobac Pharmaceuticals vs. Protokinetix | Nanobac Pharmaceuticals vs. Mymetics Corp | Nanobac Pharmaceuticals vs. Neutra Corp | Nanobac Pharmaceuticals vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |